Parallel Advisors’s Pulmonx LUNG Stock Holding History

Parallel Advisors’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$437	Hold	336	–	–	﹤0.01%	3806
2026 Q1	$433	Hold	336	–	–	﹤0.01%	3692
2025 Q4	$743	Hold	336	–	–	﹤0.01%	3349
2025 Q3	$544	Hold	336	–	–	﹤0.01%	3320
2025 Q2	$870	Hold	336	–	–	﹤0.01%	3223
2025 Q1	$2.26K	Hold	336	–	–	﹤0.01%	2941
2024 Q4	$2.28K	Hold	336	–	–	﹤0.01%	2928
2024 Q3	$2.79K	Hold	336	–	–	﹤0.01%	2792
2024 Q2	$2.13K	Hold	336	–	–	﹤0.01%	2792
2024 Q1	$3.12K	Sell	336 -15	-4%	-$176	﹤0.01%	2681
2023 Q4	$4.47K	Buy	351 +276	+368%	+$2.88K	﹤0.01%	2558
2023 Q3	$775	Hold	75	–	–	﹤0.01%	3021
2023 Q2	$983	Hold	75	–	–	﹤0.01%	2939
2023 Q1	$839	Sell	75 -75	-50%	-$740	﹤0.01%	2998
2022 Q4	$1.26K	Hold	150	–	–	﹤0.01%	2843
2022 Q3	$2K	Hold	150	–	–	﹤0.01%	2682
2022 Q2	$2K	Sell	150 -81	-35%	-$1.67K	﹤0.01%	2593
2022 Q1	$6K	Buy	231 +77	+50%	+$1.99K	﹤0.01%	2239
2021 Q4	$5K	Buy	154 +4	+3%	+$146	﹤0.01%	2404
2021 Q3	$5K	Hold	150	–	–	﹤0.01%	2364
2021 Q2	$7K	Buy	+150	New	+$6.53K	﹤0.01%	2167

Other funds holding LUNG

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Parallel Advisors's LUNG Position: Q2 2026 in Review

Parallel Advisors held its Pulmonx (LUNG) position steady in Q2 2026 at 336 shares worth $437. The position accounts for ﹤0.01% of the portfolio, ranked #3806.

Parallel Advisors first reported a position in LUNG in Q2 2021 and has held it in 21 quarters since. The position peaked at $7K in Q2 2021. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

Parallel Advisors held 336 shares of Pulmonx worth $437 as of Q2 2026.
Parallel Advisors left its Pulmonx share count unchanged in Q2 2026.
Pulmonx made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3806 holding.
Parallel Advisors first reported a position in Pulmonx in Q2 2021 and has held it in 21 quarters since.
Parallel Advisors's Pulmonx position peaked at $7K in Q2 2021.
108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.